Press Release: Achaogen : Achaogen Announces Presentations at Two Upcoming Investor Healthcare Conferences
-- Leerink February 27, 2019 at 9:30 a.m. ET ---- Cowen March 12, 2019 at 12:00 p.m. ET --
Read full article »
Achaogen develops and commercializes novel antibacterials to treat the multi-drug resistant gram-negative infections.
Read more